Publications

Nature Biopharma Dealmakers – 2022

Managing inflammatory diseases and aging with edible plant microbes

Clinical trial: Food Trial Evaluating the Efficacy of SBD111 Versus Placebo for the Clinical Dietary Management of the Metabolic Processes of Osteopenia – 2022

The aim of the trial is to determine if the SYNBIOTIC (prebiotic and probiotic), provided twice daily (capsule) will help support skeletal health in otherwise healthy postmenopausal women in the early years postmenopause (1-6 years post last menstruation) over a 12-month period.

Am Journal Physiol Endocrinol Metab – 2022

Development of a synbiotic that protects against ovariectomy induced trabecular bone loss.
Lawenius L, Gustafsson KL, Wu J, Nilsson KH, Movérare-Skrtic S, Schott EM, Soto-Girón MJ, Toledo GV, Sjögren K, Ohlsson C.

Food and Chemical Toxicology – 2022

Food safety assessment and toxicity study of the synbiotic consortium SBD111.
Easson DD, Murphy VA, Ballok AE, Soto-Giron MJ, Schott EM, Rodricks J, Toledo GV

Scientific Reports – 2021

The Edible Plant Microbiome represents a diverse genetic reservoir with functional potential in the human host

Soto-Giron MJ, Kim JN, Schott E, Tahmin C, Ishoey T, Mincer TJ, DeWalt J, Toledo G

Nutrients – 2020

Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study.